RealView Imaging

RealView Imaging develops advanced 3D holographic display and interaction systems for the medical field. Their flagship product, HOLOSCOPE™-i, utilizes proprietary Digital Light Shaping™ technology to project spatially accurate, interactive three-dimensional medical holograms directly into the air. This system integrates seamlessly with existing clinical workflows, processing data from standard CT scans and 3D ultrasound systems to provide clinicians with an intuitive and natural user experience for complex anatomical visualization.

The company was founded in 2008 by Aviad Kaufman, Shaul Gelman, and Professor Carmel Rotschild. Their founding insight centered on the critical need for a more immersive and interactive method of visualizing medical imaging data, transcending the limitations of traditional two-dimensional screens. The founders recognized the potential for true in-air volumetric display to significantly improve precision and understanding during intricate medical procedures.

RealView Imaging primarily serves physicians and medical professionals across various clinical disciplines where high-fidelity 3D anatomical understanding is paramount. The company's vision is to revolutionize medical imaging and intervention by empowering clinicians with direct interaction capabilities with precise volumetric images. They aim to enhance diagnostic accuracy, surgical planning, and procedural guidance, ultimately transforming the standard of care through innovative holographic interaction.

High-Level Overview

RealView Imaging is an Israeli startup pioneering interactive live 3D holography for medical imaging, revolutionizing procedures like heart surgery and training with its HOLOSCOPE™-i system.[1][2][3] The company serves surgeons and physicians by enabling them to "touch" and manipulate accurate, interactive holograms derived from ultrasound or CT data, solving the limitations of 2D screens that restrict precision during operations.[1][2] This addresses unmet needs in the growing medical holography market, with systems deployed in leading hospitals like Schneider Children’s Medical Centre and backed by a $10 million Series C round.[1]

Origin Story

Founded in 2008 in Yokneam, Israel, RealView Imaging emerged to tackle the constraints of traditional 2D medical imaging, creating the world's first interactive live holography platform.[1][2] Key figure Aviad Kaufman has championed the vision, describing it as providing surgeons with "X-ray eyes" for true 3D visualization.[1] Early milestones include field deployments, a 2020 installation at Israel's largest pediatric hospital, and a Series C funding round that expanded the board with global experts, fueling commercialization efforts.[1]

Core Differentiators

• World's only accurate, interactive 3D holograms: Projects "printing" imaging data in light for real-time manipulation without screens, mice, or cumbersome interfaces, unlike 2D ultrasound/CT views.[1][2]
• Precision during procedures: Enables "touching" holograms mid-surgery for enhanced accuracy, particularly in cardiology and oncology.[1]
• Upcoming body-screened holograms: Developing overlays directly on the patient for "transparent" views of organs and tools, minimizing tissue damage in precision surgeries like tumor removal.[1]

Role in the Broader Tech Landscape

RealView Imaging rides the wave of medical holography and AR/VR in healthcare, a rapidly expanding field driven by demands for minimally invasive, high-precision surgery amid aging populations and tech advancements in imaging.[1] Timing aligns with post-2020 adoption in top centers, amplified by funding and partnerships with oncology leaders, positioning it to influence surgical standards globally.[1] By freeing data from 2D confines, it accelerates training, reduces errors, and shapes ecosystem shifts toward holographic tools in prestigious hospitals and medtech firms.[1][2]

Quick Take & Future Outlook

RealView is poised for commercialization breakthroughs, with body-projected holograms enabling gentler, tumor-precise surgeries and broader adoption in oncology and pediatrics.[1] Trends like AI-enhanced imaging and regulatory nods for AR medtech will propel growth, potentially expanding influence through global installations and medtech alliances. As the pioneer in live holography, it stands to redefine surgical accuracy, turning opaque procedures into transparent triumphs.[1][2]